Announcements Trials
Browse Landscape

Phase

Phase 2 50Phase 1/2 15Phase 1 11Phase 3 10Phase NA 3Phase 2/3 2

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Locally Advanced Rectal Cancer 1

Interventions

Colonoscopy 67Blood Specimen Collection 64Standard of Care 60Exercise 59Radiosurgery 53Drug Therapy 49Radiofrequency Ablation 47Endoscopic Mucosal Resection 47Radiotherapy 45Surgical Procedures, Operative 44Methods 43Early Intervention, Educational 40Surveys and Questionnaires 39Oxaliplatin 38Laparoscopy 34Educational Status 34Fluorouracil 33Magnetic Resonance Spectroscopy 28Gemcitabine 26Biopsy 26Preoperative Exercise 25Practice Guidelines as Topic 24Control Groups 24lenvatinib 23Patient Navigation 23Electroporation 23Capecitabine 22camrelizumab 20Saline Solution 20Liver Transplantation 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × irinotecan sucrosofate × Gastrointestinal × Clear all
NCT07474103 2026-03-16

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Recruiting
49 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06894797 2025-03-25

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Peking University Cancer Hospital & Institute

Phase NA Recruiting
68 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06361316 2024-04-11

Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
53 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡